# What will AGI do for Immunotherapy Patient Adherence?

## Overview

Immunotherapy requires strict adherence to dosing schedules, but immune-related adverse events routinely derail treatment plans. Oncology clinics and care coordinators struggle to keep patients on therapy because side effects develop unpredictably between scheduled infusions. Patients frequently skip doses or abandon treatment entirely when managing these toxicities becomes overwhelming, directly compromising their clinical outcomes and wasting high-cost specialty drugs.

The failure point lies in the symptom monitoring gap between clinic visits. Patients consistently under-report early warning signs, mistaking severe immune responses for standard fatigue or fearing that reporting symptoms will cause oncologists to halt their treatment. When symptoms finally escalate to intolerable levels, the result is emergency hospitalization and forced treatment cessation. Existing patient portals rely entirely on this delayed self-reporting, leaving care teams blind to developing toxicities until it is too late for early intervention.

Care teams lack the staffing to conduct daily outreach, and current clinical workflows offer no mechanism to continuously track patient vitals at home. Without continuous surveillance that distinguishes routine discomfort from escalating toxicities, clinics lose the narrow window to adjust dosages or prescribe supportive care. This structural blind spot guarantees high attrition rates for otherwise life-saving therapeutic regimens.

## How AGI delivers it

### Services-as-Software

For Immunotherapy Patient Adherence, get the professional outcome delivered as software, priced on results, not headcount.

Routes to: services.do, services.studio

### Autonomous Agents as digital employees

For Immunotherapy Patient Adherence, hire a digital employee that does the job under earned, supervised autonomy.

Routes to: agents.do, workflows.do, management.studio, agents.management

## Related

- [Startups](https://agi.do/Problems/Immunotherapy_Patient_Adherence/Startups)

## Read more

- [The informational twin on agi.as](https://agi.as/Problems/Immunotherapy_Patient_Adherence)
- [This page on agi.do](https://agi.do/Problems/Immunotherapy_Patient_Adherence)